Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 6,762 shares at $210.00 ($1.4M) on 2022-08-03, disclosed to the SEC on 2022-08-05.
Open-market sale of $1.4M ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.00 | 1,754 | $368K | 26.1% |
| 2 | $189.76 | 1,618 | $307K | 21.7% |
| 3 | $210.50 | 170 | $36K | 2.5% |
| 4 | $215.03 | 149 | $32K | 2.3% |
| 5 | $216.21 | 398 | $86K | 6.1% |
| 6 | $216.21 | 398 |
| $86K |
| 6.1% |
| 7 | $217.61 | 440 | $96K | 6.8% |
| 8 | $217.61 | 440 | $96K | 6.8% |
| 9 | $218.71 | 541 | $118K | 8.4% |
| 10 | $218.71 | 541 | $118K | 8.4% |
| 11 | $219.53 | 99 | $22K | 1.5% |
| 12 | $220.95 | 105 | $23K | 1.6% |
| 13 | $224.00 | 5 | $1K | 0.1% |
| 14 | $225.15 | 104 | $23K | 1.7% |
| Total | $208.95 avg | 6,762 | $1.4M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |